Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A retrospective, cohort study comparing the hematologic safety profile of linezolid versus tedizolid for the treatment of Nontuberculous Mycobacteria in solid organ transplant (SOT) recipients

X
Trial Profile

A retrospective, cohort study comparing the hematologic safety profile of linezolid versus tedizolid for the treatment of Nontuberculous Mycobacteria in solid organ transplant (SOT) recipients

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Dec 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Linezolid (Primary) ; Tedizolid (Primary)
  • Indications Nontuberculous mycobacterium infections
  • Focus Adverse reactions
  • Most Recent Events

    • 17 Dec 2020 New trial record
    • 25 Oct 2020 Results (n=12) assessing clinical efficacy of tedizolid for the treatment of mycobacterium abscessus complex infections in solid organ transplant recipients, presented at the IDWeek 2020
    • 25 Oct 2020 Primary endpoint . (the hematologic effects of linezolid versus tedizolid from therapy initiation to week seven) has not been met as per results presented at the IDWeek 2020
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top